Syncona Portfolio Ltd Long-Term Concentrated

CIK: 0001725042 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 1, 2024

Total Value ($000): $157,749 (100.0% shares, 0.0% debt)

Holdings (4)

AUTL AUTOLUS THERAPEUTICS PLC 87.1%

Value ($000) $137,474 Shares 21,346,829 Est. Cost $3.03 Unrealized —

— ACHILLES THERAPEUTICS PLC 6.2%

Value ($000) $9,856 Shares 11,086,909 Est. Cost $5.01 Unrealized —

— FREELINE THERAPEUTICS HLDGS 5.9%

Value ($000) $9,327 Shares 1,466,507 Est. Cost $0.50 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.7%

Value ($000) $1,092 Shares 1,377,294 Est. Cost $3.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AUTL	AUTOLUS THERAPEUTICS PLC	21,346,829	$137,474	87.1%	$3.03	—	SPON ADS	05280R100
—	ACHILLES THERAPEUTICS PLC	11,086,909	$9,856	6.2%	$5.01	—	SPONSORED ADS	00449L102
—	FREELINE THERAPEUTICS HLDGS	1,466,507	$9,327	5.9%	$0.50	—	SPONSORED ADS	35655L107
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	1,377,294	$1,092	0.7%	$3.75	—	SPONDS ADR	00653A107